Dotagraf 15 (Gadoteric acid Ampoules) 4.189g/15ml

Dotagraf 15 is a contrast agent containing gadoteric acid, used in MRI scans to enhance image clarity. Ideal for radiology procedures requiring detailed visualization. Store between 2-8°C to maintain stability. Short-term solution for contrast-enhanced imaging needs.

Strength

4.189g/15ml

Pack Size

Storage

2-8°

Manufacturer / TM Owner

Berlis AG

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Dotagraf 15 is used as a contrast agent in magnetic resonance imaging (MRI) to improve the visibility of internal body structures. It helps radiologists detect abnormalities in soft tissues, blood vessels, and organs during diagnostic procedures. Commonly used when detailed imaging is required for conditions like tumors, inflammation, or vascular issues. Suitable for adult and pediatric patients as directed by a healthcare provider.

Side Effects

After administration, Dotagraf 15 enhances the contrast of MRI images, making it easier to distinguish between different types of tissues. Patients may experience a brief sensation of warmth or mild discomfort at the injection site. Some individuals report a metallic taste shortly after injection, which typically resolves quickly. Effects are temporary and tied to the imaging procedure.

Precautions & Warnings

Dotagraf 15 should be handled with care and administered by trained medical professionals. Patients with severe kidney disease or a history of allergic reactions to gadolinium-based contrast agents should inform their healthcare provider. Keep the product refrigerated between 2-8°C and protect from light until use. Discard any unused portion after opening to ensure sterility.

Avoid Interactions

No known direct drug interactions with Dotagraf 15 have been reported, but patients should disclose all medications to their healthcare provider. Caution is advised when using other contrast agents or medications affecting kidney function. Alcohol consumption is not known to interact but should be avoided if advised by a doctor. Always follow medical guidance regarding pre- and post-procedure care.

Frequently Asked Questions

Dotagraf 15 is a contrast agent used to enhance MRI images for better visualization of internal structures.

Store Dotagraf 15 between 2-8°C and protect from light until use.

Use in pediatric patients should be determined by a healthcare provider based on individual needs.

Common effects include a brief sensation of warmth, mild discomfort at the injection site, or a metallic taste.

Patients with severe kidney disease should consult their doctor before using Dotagraf 15.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.